e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

View Full List

My Watchlist

01 Quantum Inc

AEye, Inc. - Class A Common Stock

Ameramex Intl Inc

Anything Technologies Media Inc

Burlington Stores, Inc. Common Stock

COMPASS Pathways Plc - American Depository Shares

Cardinal Energy Ltd Ord

Cematrix Corp

Cinedigm Corp - Class A Common Stock

Dell Technologies Inc. Class C Common Stock

Eagle Graphite Inc

Ferrellgas Partnrs LP New

Fidelity Disruptors ETF

Fidelity MSCI Financials Index ETF

Futu Holdings Limited - American Depositary Shares

GreenPower Motor Company Inc. - Common Shares

Inspire Medical Systems, Inc. Common Stock

Invesco Dorsey Wright Technology Momentum ETF

Ituran Location and Control Ltd. - Ordinary Shares

John Bean Technologies Corporation Common Stock

Kddi Corp

Lifeward Ltd. - Ordinary Shares

Mill City Ventures III, Ltd. - Common Stock

Momentus Inc. - Class A Common Stock

Old National Bancorp - Depositary Shares

Pan American Silver Corp.

Parex Resources Inc

Parkland Inc Fd Trut

Peoples Ltd

Piper Sandler Companies Common Stock

Planet Green Holdings Corp. Common Stock

Safe Bulkers, Inc Common Stock ($0.001 par value)

Siebert Financial Corp. - Common Stock

Silicon Laboratories, Inc. - Common Stock

Skyharbour Res Ltd Ord

Smith Douglas Homes Corp. Class A Common Stock

Sprout Social, Inc - Class A Common Stock

State Street Communication Services Select Sector SPDR ETF

State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF

Super Micro Computer, Inc. - Depositary Shares

Talos Energy, Inc. Common Stock

Telus International [Cda] Inc

Tenable Holdings, Inc. - Common Stock

U.S. Small Cap Portfolio: ETF Class Shares

Unity Wealth Partners Dynamic Capital Appreciation & Options ETF

Vanguard Intermediate-Term Corporate Bond ETF

Vanguard U.S. Multifactor ETF

Wetouch Technology Inc. - Common Stock

WisdomTree Efficient Rare Earth Plus Strategic Metals Fund

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Articles published by bioAffinity Technologies, Inc.

< Previous 1 2 3 4 5 Next >

bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update

November 14, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF BIAFW

bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales

November 06, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF BIAFW

bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference

October 10, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF BIAFW

bioAffinity Technologies to Participate in the H.C. Wainwright Global Investment Conference

September 07, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF BIAFW

bioAffinity Technologies Reports Second Quarter 2023 Financial Results and Provides Business Update

August 14, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF BIAFW

AMA Issues CPT Code for bioAffinity Technologies’ CyPath® Lung Test for Early-Stage Lung Cancer

July 12, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF BIAFW

bioAffinity Technologies Presents Research Findings at UMass RNA Therapeutics Symposium

June 15, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF BIAFW

bioAffinity Technologies Presents Research Findings at CYTO 2023

May 22, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF BIAFW

bioAffinity Technologies Reports First Quarter 2023 Financial Results

May 15, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF

bioAffinity Technologies Names Michael Dougherty as Chief Financial Officer

May 01, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF BIAFW

bioAffinity Technologies Presents at Cleveland Clinic Lung Cancer Symposium

April 25, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF BIAFW

bioAffinity Technologies to Ring Nasdaq Closing Bell Today

April 05, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF

bioAffinity Technologies Reports Fourth Quarter and Full Year 2022 Financial Results

March 31, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF BIAFW

bioAffinity Technologies Announces Publication of Peer-Reviewed Paper on Proprietary Beads Used in CyPath® Lung for Noninvasive Detection of Early-Stage Lung Cancer

March 28, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF

bioAffinity Technologies to Report Fourth Quarter 2022 Financial Results on March 31, 2023

March 24, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF

bioAffinity Technologies Appoints Julie Anne Overton Director of Corporate Communications

February 13, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF

bioAffinity Technologies Announces Publication of Results of Clinical Trial in Peer-Reviewed Journal Respiratory Research

January 24, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF

bioAffinity Technologies Announces Notice to Award U.S. Patent Protecting Novel Compounds for Specific Delivery of Cancer Treatments

January 04, 2023

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF

bioAffinity Technologies Expands Diagnostic Division with Promotions and New Hires to Strengthen Clinical Bench

December 15, 2022

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF

bioAffinity Technologies Presents Proprietary Cancer Therapeutic Research at Joint ASCB-EMBO Meeting

December 01, 2022

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF

bioAffinity Technologies Reports Third Quarter 2022 Financial Results and Provides Business Update

November 14, 2022

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF

bioAffinity Technologies Announces Sheila Habib, MD and David Hill, MD Join the Company’s Scientific and Medical Advisory Board

November 10, 2022

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF

bioAffinity Technologies to Report Third Quarter 2022 Financial Results

November 08, 2022

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF

bioAffinity Technologies Announces Award of Therapeutic Patents in China, Mexico and Australia

October 25, 2022

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF

bioAffinity Technologies Presents Results from Flow Cytometry Analysis of the Lung at CHEST Conference

October 12, 2022

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF

bioAffinity Technologies Receives Additional $7.7M from Exercise of Warrants, Total Capital from Public Offering Increases to Approximately $15.6M

September 28, 2022

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF

bioAffinity Technologies Publishes Peer-Reviewed Results of High-Throughput Flow Cytometry Use for Evaluating Lung Health in PLOS ONE

September 14, 2022

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF

bioAffinity Technologies, Inc. Announces Closing of $7.8 Million Initial Public Offering

September 06, 2022

From bioAffinity Technologies, Inc.

Via Business Wire

Tickers BIAF

bioAffinity Technologies Announces Pricing of IPO

September 01, 2022

From bioAffinity Technologies, Inc.

Via Business Wire

bioAffinity Technologies Presents its Cancer Therapeutic Research at Joint ASCB-EMBO Meeting

December 06, 2021

From bioAffinity Technologies, Inc.

Via Business Wire

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy